JP2016520133A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520133A5
JP2016520133A5 JP2016517049A JP2016517049A JP2016520133A5 JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5 JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5
Authority
JP
Japan
Prior art keywords
group
alkyl
carbon atoms
alkoxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016517049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520133A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/040286 external-priority patent/WO2014194226A2/en
Publication of JP2016520133A publication Critical patent/JP2016520133A/ja
Publication of JP2016520133A5 publication Critical patent/JP2016520133A5/ja
Pending legal-status Critical Current

Links

JP2016517049A 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物 Pending JP2016520133A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361829759P 2013-05-31 2013-05-31
US61/829,759 2013-05-31
US201361839609P 2013-06-26 2013-06-26
US61/839,609 2013-06-26
PCT/US2014/040286 WO2014194226A2 (en) 2013-05-31 2014-05-30 Methods of treatment and compositions with xanthine oxidase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034081A Division JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Publications (2)

Publication Number Publication Date
JP2016520133A JP2016520133A (ja) 2016-07-11
JP2016520133A5 true JP2016520133A5 (cg-RX-API-DMAC7.html) 2017-07-06

Family

ID=50983231

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016517049A Pending JP2016520133A (ja) 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Country Status (9)

Country Link
US (2) US20140357683A1 (cg-RX-API-DMAC7.html)
JP (2) JP2016520133A (cg-RX-API-DMAC7.html)
CN (1) CN105579037A (cg-RX-API-DMAC7.html)
CA (1) CA2913755A1 (cg-RX-API-DMAC7.html)
MX (1) MX2015016494A (cg-RX-API-DMAC7.html)
PH (1) PH12015502679A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201509738RA (cg-RX-API-DMAC7.html)
TW (1) TW201536284A (cg-RX-API-DMAC7.html)
WO (1) WO2014194226A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018005345A (es) * 2015-10-28 2018-08-14 Sun Pharmaceutical Ind Ltd Composiciones farmaceuticas de dimetil fumarato.
CN105769766B (zh) * 2016-03-24 2018-07-06 长沙佰顺生物科技有限公司 一种托匹司他纳米乳及其制备方法
JP7108384B2 (ja) * 2016-07-13 2022-07-28 日本ケミファ株式会社 2-[3-シアノ-4-(2-メチルプロポキシ)フェニル]-4-メチルチアゾール-5-カルボン酸の口腔内崩壊錠
DK3484862T3 (da) * 2016-07-18 2021-11-08 Arthrosi Therapeutics Inc Forbindelser, sammensætninger og fremgangsmåder til behandling eller forebyggelse af et symptom, der er forbundet med gigt eller hyperurikæmi
US12419854B2 (en) 2018-12-06 2025-09-23 Arthrosi Therapeutics, Inc. Methods for treating or preventing gout or hyperuricemia
SG11202105745UA (en) 2018-12-06 2021-06-29 Arthrosi Therapeutics Inc Crystalline forms of a compound for treating or preventing gout or hyperuricemia
CN113924145A (zh) * 2019-06-04 2022-01-11 日本化学药品株式会社 痛风或高尿酸血症的治疗药
PE20240242A1 (es) * 2021-06-15 2024-02-16 Lg Chemical Ltd Una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilico
CN115252567A (zh) * 2022-07-08 2022-11-01 广西纯正堂制药有限公司 非布司他渗透泵缓释片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5544163A (en) 1994-03-08 1996-08-06 Excel, Inc. Expandable telecommunications system
DK1488790T3 (da) 2002-03-28 2014-10-13 Teijin Pharma Ltd Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat
PL1757610T3 (pl) 2004-06-14 2011-10-31 Nippon Chemiphar Co Skondensowana pochodna pirymidyny oraz inhibitor oksydazy ksantynowej
WO2007043457A1 (ja) 2005-10-07 2007-04-19 Astellas Pharma Inc. トリアリールカルボン酸誘導体
CN101646440A (zh) * 2007-01-19 2010-02-10 武田制药北美公司 使用黄嘌呤氧化还原酶抑制剂和抗炎剂预防痛风突发或减少痛风突发次数的方法
KR101772963B1 (ko) 2009-03-31 2017-08-31 깃세이 야쿠힌 고교 가부시키가이샤 인돌리진 유도체 및 그 의약용도
CN101773498B (zh) * 2009-12-30 2012-06-20 青岛黄海制药有限责任公司 一种含有非布司他的口服缓控释制剂的制备方法
JP5865904B2 (ja) * 2010-06-16 2016-02-17 タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド キサンチンオキシドレダクターゼ阻害剤またはキサンチンオキシダーゼ阻害剤の新規の調節放出剤形
MX339452B (es) 2010-06-16 2016-05-27 Teijin Pharma Ltd Tableta con nucleo recubierto de liberacion controlada.
CN102641255A (zh) * 2012-05-08 2012-08-22 南方医科大学 一种治疗痛风的非布索坦渗透泵控释片及其制备方法

Similar Documents

Publication Publication Date Title
JP2016520133A5 (cg-RX-API-DMAC7.html)
RU2011143741A (ru) Производное индолизина и его применение в медицинских целях
JP2016512520A5 (cg-RX-API-DMAC7.html)
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JP2011513305A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2013531029A5 (cg-RX-API-DMAC7.html)
JP2013528655A5 (cg-RX-API-DMAC7.html)
JP2016518437A5 (cg-RX-API-DMAC7.html)
JP2012508252A5 (cg-RX-API-DMAC7.html)
JP2014504622A5 (cg-RX-API-DMAC7.html)
JP2012184234A5 (cg-RX-API-DMAC7.html)
JP2017537940A5 (cg-RX-API-DMAC7.html)
JP2012041349A5 (cg-RX-API-DMAC7.html)
JP2015522650A5 (cg-RX-API-DMAC7.html)
PH12014501277A1 (en) Kinase inhibitors
JP2013508288A5 (cg-RX-API-DMAC7.html)
JP2017504635A5 (cg-RX-API-DMAC7.html)
ZA201802312B (en) A group of compounds used for the treatment or prevention of hyperuricemia or gout
JP2016507575A5 (cg-RX-API-DMAC7.html)
JP2013063968A5 (cg-RX-API-DMAC7.html)
JP2018533593A5 (cg-RX-API-DMAC7.html)
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2015521156A5 (cg-RX-API-DMAC7.html)
JP2017510660A5 (cg-RX-API-DMAC7.html)